Cornea / Ocular Surface

An updated surgical technique restores sensation to patients with corneal anesthesia

Five Things We Learned This Month

Tumbling Es and Philanthropy

Why persist with preservatives? Those present in topical glaucoma therapies don’t improve the active compound’s efficacy – and cause ocular surface disease in many patients

The first and only EU-approved ciclosporin eyedrop has arrived – what does this mean for patients with severe keratitis in dry eye disease?

Could femtosecond laser-assisted keratopigmentation represent a new way of correcting presbyopia?

A naturally-occurring proteogylcan, decorin, can effect CXL-like biomechanical changes when applied to ex-vivo human and porcine corneas.

Second corneal transplants are far more likely to be rejected than first-time grafts – but now that we know why, we might be able to prevent it

OCT angiography (OCT-A) is poised to augment, and in many cases, replace traditional methods of examining the retinal and choroidal vasculature – once certain technical challenges are addressed.

As many as six in every ten patients with glaucoma have ocular surface disease – and this can have a huge impact on their daily lives. We explore why, and what can be done.